Fontes-Cal TCM, Mattos RT, Medeiros NI, et al. Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.708959.
Article PubMed PubMed Central Google Scholar
Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18:223–38. https://doi.org/10.1038/s41575-020-00381-6.
Article PubMed Google Scholar
Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann Ny Acad Sci. 2013;1281:106–22. https://doi.org/10.1111/nyas.12016.
CAS Article PubMed Google Scholar
Michelotti A, de Scordilli M, Palmero L, et al. NAFLD-related hepatocarcinoma: the malignant side of metabolic syndrome. Cells-Basel. 2021;10:2034. https://doi.org/10.3390/cells10082034.
CAS Article Google Scholar
Zhang C, Yang M. The emerging factors and treatment options for NAFLD-related hepatocellular carcinoma. Cancers. 2021;13:3740. https://doi.org/10.3390/cancers13153740.
CAS Article PubMed PubMed Central Google Scholar
Juanola O, Martínez-López S, Francés R, et al. Non-alcoholic fatty liver disease: metabolic, genetic, epigenetic and environmental risk factors. Int J Env Res Pub He. 2021;18:5227. https://doi.org/10.3390/ijerph18105227.
CAS Article Google Scholar
Singal AG, El-Serag HB. Rational screening approaches for HCC in NAFLD patients. J Hepatol. 2021. https://doi.org/10.1016/j.jhep.2021.08.028.
Article PubMed Google Scholar
Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World J Gastroentero. 2014;23:7392–402. https://doi.org/10.3748/wjg.v20.
Article Google Scholar
Starekova J, Hernando D, Pickhardt PJ, et al. Quantification of liver fat content with CT and MRI: state of the art. Radiology. 2021. https://doi.org/10.1148/radiol.2021204288.
Article PubMed Google Scholar
Souabni M, Hammouda O, Romdhani M, et al. Benefits of daytime napping opportunity on physical and cognitive performances in physically active participants: a systematic review. Sports Med. 2021. https://doi.org/10.1007/s40279-021-01482-1.
Article PubMed Google Scholar
Wang Y, Zeng Y, Zhang X, et al. Daytime napping duration is positively associated with risk of hyperuricemia in a Chinese population. J Clin Endocrinol Metab. 2021;106:e2096–105. https://doi.org/10.1210/clinem/dgab043.
Article PubMed Google Scholar
Lin L, Lu C, Chen W, et al. Daytime napping and nighttime sleep duration with incident diabetes mellitus: a cohort study in Chinese older adults. Int J Env Res Pub He. 2021;18:5012. https://doi.org/10.3390/ijerph18095012.
CAS Article Google Scholar
Patterson PD, Liszka MK, Mcilvaine QS, et al. Does the evidence support brief (≤30-mins), moderate (31–60-mins), or long duration naps (61+ mins) on the night shift? A systematic review. Sleep Med Rev. 2021;59:101509. https://doi.org/10.1016/j.smrv.2021.101509.
Article PubMed Google Scholar
Fu J, Zhang X, Moore JB, et al. Midday nap duration and hypertension among middle-aged and older Chinese adults: a nationwide retrospective cohort study. Int J Env Res Pub He. 2021;18:3680. https://doi.org/10.3390/ijerph18073680.
Article Google Scholar
Jarvis H, Craig D, Barker R, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLoS Med. 2020;17:e1003100. https://doi.org/10.1371/journal.pmed.1003100.
CAS Article PubMed PubMed Central Google Scholar
Maier S, Wieland A, Cree-Green M, et al. Lean NAFLD: an underrecognized and challenging disorder in medicine. Rev Endocr Metab Disord. 2021;22:351–66. https://doi.org/10.1007/s11154-020-09621-1.
Article PubMed PubMed Central Google Scholar
Bastien M, Poirier P, Lemieux I, et al. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56:369–81. https://doi.org/10.1016/j.pcad.2013.10.016.
Article PubMed Google Scholar
Vgontzas AN, Pejovic S, Zoumakis E, et al. Daytime napping after a night of sleep loss decreases sleepiness, improves performance, and causes beneficial changes in cortisol and interleukin-6 secretion. Am J Physiol-Endoc Metab. 2007;292:E253–61. https://doi.org/10.1152/ajpendo.00651.2005.
CAS Article Google Scholar
Devine JK, Wolf JM. Determinants of cortisol awakening responses to naps and nighttime sleep. Psychoneuroendocrino. 2016;63:128–34. https://doi.org/10.1016/j.psyneuen.2015.09.016.
CAS Article Google Scholar
Abulizi A, Camporez J, Jurczak MJ, et al. Adipose glucocorticoid action influences whole-body metabolismvia modulation of hepatic insulin action. FASEB J. 2019;33:8174–85. https://doi.org/10.1096/fj.201802706R.
CAS Article PubMed PubMed Central Google Scholar
Abulizi A, Camporez J, Zhang D, et al. Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice. Metabolism. 2019;93:1–9. https://doi.org/10.1016/j.metabol.2018.12.003.
CAS Article PubMed Google Scholar
Rasch B, Dodt C, Mölle M, et al. Sleep-stage-specific regulation of plasma catecholamine concentration. Psychoneuroendocrino. 2007;32:884–91. https://doi.org/10.1016/j.psyneuen.2007.06.007.
CAS Article Google Scholar
Smolensky MH, Hermida RC, Castriotta RJ, et al. Role of sleep-wake cycle on blood pressure circadian rhythms and hypertension. Sleep Med. 2007;8:668–80. https://doi.org/10.1016/j.sleep.2006.11.011.
Article PubMed Google Scholar
Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med. 2009;150:776–83. https://doi.org/10.7326/0003-4819-150-11-200906020-00005.
Article PubMed PubMed Central Google Scholar
Kang T, Boland BB, Jensen P, et al. Characterization of signaling pathways associated with pancreatic β-cell adaptive flexibility in compensation of obesity-linked diabetes in db/db mice. Mol Cell Proteomics. 2020;19:971–93. https://doi.org/10.1074/mcp.RA119.001882.
CAS Article PubMed PubMed Central Google Scholar
Jullian-Desayes I, Trzepizur W, Boursier J, et al. Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis. Sleep Med. 2021;77:357–64. https://doi.org/10.1016/j.sleep.2020.04.004.
Article PubMed Google Scholar
Hirono H, Watanabe K, Hasegawa K, et al. Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea. World J Clin Cases. 2021;9:5112–25. https://doi.org/10.12998/wjcc.v9.i19.5112.
Article PubMed PubMed Central Google Scholar
Parola M, Vajro P. Nocturnal hypoxia in obese-related obstructive sleep apnea as a putative trigger of oxidative stress in pediatric NAFLD progression. J Hepatol. 2016;65:470–2. https://doi.org/10.1016/j.jhep.2016.05.042.
Article PubMed Google Scholar
Lucassen EA, Rother KI, Cizza G. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann Ny Acad Sci. 2012;1264:110–34. https://doi.org/10.1111/j.1749-6632.2012.06655.x.
CAS Article PubMed Google Scholar
McHill AW, Melanson EL, Higgins J, et al. Impact of circadian misalignment on energy metabolism during simulated nightshift work. Proc Natl Acad Sci. 2014;111:17302–7. https://doi.org/10.1073/pnas.1412021111.
CAS Article PubMed PubMed Central Google Scholar
Picó C, Palou M, Pomar CA, et al. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2021. https://doi.org/10.1007/s11154-021-09687-5.
Article PubMed PubMed Central Google Scholar
Gallardo N, Bonzón-Kulichenko E, Fernández-Agulló T, et al. Tissue-specific effects of central leptin on the expression of genes involved in lipid metabolism in liver and white adipose tissue. Endocrinology. 2007;148:5604–10. https://doi.org/10.1210/en.2007-0933.
CAS Article PubMed Google Scholar
Han H, Chung SI, Park HJ, et al. Obesity-induced vitamin D deficiency contributes to lung fibrosis and airway hyperresponsiveness. Am J Resp Cell Mol. 2021;64:357–67. https://doi.org/10.1165/rcmb.2020-0086OC.
CAS Article Google Scholar
Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism. 2016;65:1038–48. https://doi.org/10.1016/j.metabol.2015.12.012.
CAS Article PubMed Google Scholar
Souza CO, Teixeira AA, Biondo LA, et al. Palmitoleic acid reduces the inflammation in LPS-stimulated macrophages by inhibition of NFκB, independently of PPARs. Clin Exp Pharmacol Physiol. 2017;44:566–75. https://doi.org/10.1111/1440-1681.12736.
CAS Article PubMed Google Scholar
Kanwal F, Kramer JR, Mapakshi S, et al. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology. 2018;155:1828–37. https://doi.org/10.1053/j.gastro.2018.08.024.
Article PubMed Google Scholar
